Literature DB >> 486471

Effect of different physical states of phospholipid substrates on partially purified platelet phospholipase A2 activity.

R Kannagi, K Koizumi.   

Abstract

Partial purification of alkaline phospholipase A2 (EC 3.1.1.4) from rabbit platelets was carried out and the effect of different physical states of the substrate phosphatidylcholine on the activity was investigated. (1) The enzyme was purified about 1020-fold by means of Sephadex gel chromatography after extraction from a particulate fraction of rabbit platelets, followed by CM-cellulose chromatography, and had a molecular weight of approx. 12 000 as determined by gel chromatography. (2) The activity of the purified enzyme was enhanced by the addition of detergents. Sodium deoxycholate and sodium cholate markedly stimulated the activity, and the effect of these substances was observed well below the critical micelle concentrations. Triton X-100 stimulated the activity moderately, and the activation was observed only above the critical micelle concentration. (3) The addition of negatively charged phospholipids to the substrate egg phosphatidylcholine induced a moderate activation of hydrolysis. (4) The addition of long-chain cation to the substrate induced an inhibition of the activity, whereas the addition of long-chain anion activated the hydrolysis of egg phosphatidylcholine, but did not activate the hydrolysis of phosphatidylcholine in the total lipid extract of rabbit platelets. (5) Hydrolysis of dimyristoyl phosphatidylcholine increased in the temperature region of the phase transition of the substrate. Addition of cholesterol at the concentration of 20 mol% diminished the effect of phase transition. (6) Release of [1-14C]arachidonic acid from an equimolar mixture of egg phosphatidylcholine with dipalmitoyl or distearoyl phosphatidylcholine was activated at the temperature of 0 degrees C or 20 degrees C, respectively. From these results, we suggest that platelet phospholipase A2 can be activated to release fatty acids from the platelet phospholipids at the domains within membranes, where exist the structural irregularities and/or accumulation of negative charge within the bilayers.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486471     DOI: 10.1016/0005-2736(79)90130-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Malignant hyperthermia: molecular defects in membrane permeability.

Authors:  K S Cheah; A M Cheah
Journal:  Experientia       Date:  1985-05-15

2.  Acyl chain and head group regulation of phospholipid catabolism in senescing carnation flowers.

Authors:  J H Brown; J A Chambers; J E Thompson
Journal:  Plant Physiol       Date:  1991-03       Impact factor: 8.340

3.  Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids.

Authors:  M J Broekman; J W Ward; A J Marcus
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

Review 4.  [Eicosanoids and phospholipases].

Authors:  M Goerig; A J Habenicht; G Schettler
Journal:  Klin Wochenschr       Date:  1985-04-01

5.  Arachidonate cannot be released directly from diacyl-sn-glycero-3-phosphocholine in thrombin-stimulated platelets.

Authors:  O Colard; M Breton; D Pepin; F Chevy; G Bereziat; J Polonovski
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

6.  Effects of cholesterol on physical properties of human erythrocyte membranes: impact on susceptibility to hydrolysis by secretory phospholipase A2.

Authors:  Anne L Heiner; Elizabeth Gibbons; Jeremy L Fairbourn; Laurie J Gonzalez; Chisako O McLemore; Taylor J Brueseke; Allan M Judd; John D Bell
Journal:  Biophys J       Date:  2008-01-11       Impact factor: 4.033

7.  The phospholipase A2 from human platelets.

Authors:  R Apitz-Castro; M R Cruz; M Mas; M K Jain
Journal:  Agents Actions       Date:  1981-12

8.  Modulation of phospholipase A2 activity in human synovial fluid by cations.

Authors:  A A Fawzy; R Dobrow; R C Franson
Journal:  Inflammation       Date:  1987-12       Impact factor: 4.092

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.